about
Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomesFunctional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heartTwo weeks of metformin treatment enhances mitochondrial respiration in skeletal muscle of AMPK kinase dead but not wild type miceGene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathwaysImpaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle.Exercise training with dietary counselling increases mitochondrial chaperone expression in middle-aged subjects with impaired glucose toleranceDeletion of the mitochondrial flavoprotein apoptosis inducing factor (AIF) induces beta-cell apoptosis and impairs beta-cell mass.Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity.Hemiparetic stroke alters vastus lateralis myosin heavy chain profiles between the paretic and nonparetic musclesIntegration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.Role of skeletal muscle mitochondrial density on exercise-stimulated lipid oxidation.Mitochondrial complex I deficiency enhances skeletal myogenesis but impairs insulin signaling through SIRT1 inactivation.Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity.Analyte flux at a biomaterial-tissue interface over time: implications for sensors for type 1 and 2 diabetes mellitus.Exchange kinetics by inversion transfer: integrated analysis of the phosphorus metabolite kinetic exchanges in resting human skeletal muscle at 7 TTargeting mitochondrial alterations to prevent type 2 diabetes--evidence from studies of dietary redox-active compounds.Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus.Oxidative phosphorylation flexibility in the liver of mice resistant to high-fat diet-induced hepatic steatosis.Mitochondrial medicine for aging and neurodegenerative diseasesInsulin Resistance Is Not Associated with an Impaired Mitochondrial Function in Contracting Gastrocnemius Muscle of Goto-Kakizaki Diabetic Rats In VivoMitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.Independent effect of type 2 diabetes beyond characteristic comorbidities and medications on immediate but not continued knee extensor exercise hyperemia.Skeletal muscle alkaline Pi pool is decreased in overweight-to-obese sedentary subjects and relates to mitochondrial capacity and phosphodiester content.Mitochondrial Epigenetic Changes Link to Increased Diabetes Risk and Early-Stage Prediabetes Indicator.Metabolic flexibility and insulin resistanceExercise therapy in type 2 diabetes.PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.The comparison of muscle strength and short-term endurance in the different periods of type 2 diabetesInsulin release, peripheral insulin resistance and muscle function in protein malnutrition: a role of tricarboxylic acid cycle anaplerosis.Effects of gas exchange on acid-base balance.Genetic downregulation of receptor-interacting protein 140 uncovers the central role of Akt signalling in the regulation of fatty acid oxidation in skeletal muscle cells.Recent progress in studies on the health benefits of pyrroloquinoline quinone.Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy.Thyroid hormone effect on human mitochondria measured by flow cytometry.Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistance.Naringin Improves Neuronal Insulin Signaling, Brain Mitochondrial Function, and Cognitive Function in High-Fat Diet-Induced Obese Mice.H55N polymorphism as a likely cause of variation in citrate synthase activity of mouse skeletal muscle.Comparison of in vivo postexercise phosphocreatine recovery and resting ATP synthesis flux for the assessment of skeletal muscle mitochondrial function.
P2860
Q28383016-2D8EFC30-0707-4E16-A79A-B28C70EB6209Q28389334-5062A22B-AB58-4FEC-9D9C-8B25CE8610A1Q28485110-2104F19E-A93D-4B9C-96B0-163CC43A3B1BQ28752071-3804CCF5-0D67-4467-8BB1-47B6F65FFF4AQ30438252-DFF87BE6-111C-4968-B143-1940949B6F20Q33326031-4C019866-12DD-49CA-B898-021EFB3393D4Q33406263-10AEF691-B07D-41BC-80E7-720D569447E9Q33419373-3B7CD85A-145F-4F14-B982-5DE075F362CFQ33589062-2F934AF8-8CEE-4C33-80AD-0702E3864034Q33756868-9AE9F642-875D-4159-A22F-B346AF56B024Q33762245-65D03359-7497-4102-A942-6245D871A97EQ33779662-2DB05D30-9D7A-4F1C-BF2F-1CEDDFAE53D4Q33924199-6A123EC7-E5BF-4E39-AE9A-9709F3D45434Q33931142-BCB12226-FFCA-4B38-9DB9-E6575FD98172Q34022206-9B979D1C-A412-4D82-8BEF-ADCC3F180D1FQ34209072-52B5E3CC-683A-46C1-BFD7-372CEEC97DFAQ34339675-23246266-8790-48DE-847C-7CBE1E5E612CQ34412057-665E867B-926D-431B-AA8E-C46755932379Q34589466-A465B0AC-3855-40F3-9777-1520EA1CBFC6Q35180004-E0945849-05FF-4C1F-AEB1-384C1E96B177Q35606693-987BDDCA-2B6D-4204-9AA3-E7A0A93172EDQ35658153-7FB0D891-A4AB-4077-AE01-C6CBD8741050Q35660977-FC194343-2A2B-4DF3-B026-5B84845EE440Q35921779-54CA40B8-9084-4085-9F72-7826C8FA4963Q36536158-0C2E6B3D-EB90-4CEA-8807-FF1E4F9F3332Q36958809-7DDDAECE-DD26-4912-9B2F-81FF8A36E66FQ36976967-38AABF83-64D1-4730-8C81-9C4B88048045Q37412024-23983252-12A0-4465-AC9E-0A3A3BC64866Q37412140-378823A6-4BB4-447E-B0CD-B43B2F9BB2A0Q37593185-D6161B7A-7393-4DC8-B43B-16B2BFFF20D3Q37641409-7949C28E-B05C-43DD-9F41-94D577F0D497Q38110759-C8CB9788-95D0-4AE5-A9D9-1D1A3C8274E0Q38322298-C19F02B7-F4D6-499E-9FFF-A20A056E4272Q38546045-C1B467AA-C916-4B6B-BD0C-57A2DA171BF8Q38676080-DC5423E6-4B6F-40F1-89C4-38FD9C129378Q39772297-552BB292-5717-443E-800A-BD8934F2C4F5Q40693150-CF1ADC0F-E13B-4A43-AD82-3B5D9FE3810FQ42167847-5B9E0B2A-63B8-428B-93B3-915D4DACA6D0Q42934833-D8CC46A3-0DB8-4C82-8964-E0E873E82116Q42953342-F284F05E-5719-4B0A-8E77-5D217A7A36A6
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mitochondrial oxidative function and type 2 diabetes.
@ast
Mitochondrial oxidative function and type 2 diabetes.
@en
type
label
Mitochondrial oxidative function and type 2 diabetes.
@ast
Mitochondrial oxidative function and type 2 diabetes.
@en
prefLabel
Mitochondrial oxidative function and type 2 diabetes.
@ast
Mitochondrial oxidative function and type 2 diabetes.
@en
P2093
P2860
P356
P1476
Mitochondrial oxidative function and type 2 diabetes.
@en
P2093
Flemming Dela
Rasmus Rabøl
Robert Boushel
P2860
P304
P356
10.1139/H06-071
P577
2006-12-01T00:00:00Z